Parvovirus B19 infection and autoimmune disease

被引:118
作者
Lehmann, HW
von Landenberg, P
Modrow, S
机构
[1] Univ Regensburg, Inst Med Mikrobiol & Hyg, D-93053 Regensburg, Germany
[2] Sachs Krankenhaus Hubertusburg, Klin Kinder & Jugendmed, D-04779 Wermsdorf, Germany
[3] Univ Klinikum Regensburg, Klin & Poliklin Innere Med 1, D-93042 Regensburg, Germany
关键词
parvovirus B19 infection; arthralgia-arthritis; juvenile rheumatoid arthritis; anti-phospholipid syndrome; autoimmune reaction;
D O I
10.1016/S1568-9972(03)00014-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human parvovirus B19 infections may cause a widespread benign and self-limiting disease in children and adults, known as erythema infectiosum or fifth disease. A variety of further manifestations are associated with the infection such as arthralgias, arthritis, leukopenia and thrombocytopenia, anemia and vasculitis, spontaneous abortion and hydrops fetalis in pregnant women. Both in children and adults parvovirus B19 infections have been frequently implicated. as a cause or trigger of various forms of autoimmune diseases affecting joints, connective tissue and large and small vessels. In addition,. autoimmune neutropenia, thrombocytopenia and hemolytic anemia are known as sequelae of B19 infection. The molecular basis of the autoimmune phenomena and resultant pathogenesis is unclear. The involvement of molecular mimicry between cellular and viral proteins, the induction of enhanced cytokine production via the viral transactivator protein NS1 and the phospholipase A2-like activity of the capsid protein VP1 may contribute to the induction of autoimmune reactions. All the known data and the potential mechanisms involved in the pathogenesis will be discussed in this review. (C) 2003 Elsevier Science B.V All rights reserved.
引用
收藏
页码:218 / 223
页数:6
相关论文
共 45 条
[11]   The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity [J].
Dorsch, S ;
Liebisch, G ;
Kaufmann, B ;
von Landenberg, P ;
Hoffmann, JH ;
Drobnik, W ;
Modrow, S .
JOURNAL OF VIROLOGY, 2002, 76 (04) :2014-2018
[12]   Evidence for persistence of parvovirus B19 DNA in livers of adults [J].
Eis-Hübinger, AM ;
Reber, U ;
Abdul-Nour, T ;
Glatzel, U ;
Lauschke, H ;
Pütz, U .
JOURNAL OF MEDICAL VIROLOGY, 2001, 65 (02) :395-401
[13]   Regulation of tumor necrosis factor alpha promoter by human parvovirus B19NS1 through activation of AP-1 and AP-2 [J].
Fu, Y ;
Ishii, KK ;
Munakata, Y ;
Saitoh, T ;
Kaku, M ;
Sasaki, T .
JOURNAL OF VIROLOGY, 2002, 76 (11) :5395-5403
[14]  
Gabriel SE, 1999, ARTHRITIS RHEUM, V42, P1255, DOI 10.1002/1529-0131(199906)42:6<1255::AID-ANR23>3.0.CO
[15]  
2-P
[16]   Role of parvovirus B19 infection in childhood idiopathic thrombocytopenic purpura [J].
Heegaard, ED ;
Rosthoj, S ;
Petersen, BL ;
Nielsen, S ;
Pedersen, FK ;
Hornsleth, A .
ACTA PAEDIATRICA, 1999, 88 (06) :614-617
[17]   Human parvovirus B19 [J].
Heegaard, ED ;
Brown, KE .
CLINICAL MICROBIOLOGY REVIEWS, 2002, 15 (03) :485-+
[18]   Acute parvovirus B19 infection in connection with a flare of systemic lupus erythematodes in a female patient [J].
Hemauer, A ;
Beckenlehner, K ;
Wolf, H ;
Lang, B ;
Modrow, S .
JOURNAL OF CLINICAL VIROLOGY, 1999, 14 (01) :73-77
[19]   Polymerase chain reaction amplification of archival material for Epstein-Barr virus, cytomegalovirus, human herpesvirus 6, and parvovirus B19 in children with bone marrow hemophagocytosis [J].
Hoang, MP ;
Dawson, B ;
Rogers, ZR ;
Scheuermann, RH ;
Rogers, BB .
HUMAN PATHOLOGY, 1998, 29 (10) :1074-1077
[20]   Circulating tumour necrosis factor-α and interferon-γ are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue [J].
Kerr, JR ;
Barah, F ;
Mattey, DL ;
Laing, I ;
Hopkins, SJ ;
Hutchinson, IV ;
Tyrrell, DAJ .
JOURNAL OF GENERAL VIROLOGY, 2001, 82 :3011-3019